KYVERNA THERAPEUTICS INC
KYTX
Health Care
1
exclusion reason
1 theme
KYVERNA THERAPEUTICS INC is screened out under 1 exclusion reason spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Excluded under our animal exploitation screen based on the company's commercial activities involving animals. This is a policy-based exclusion — identified through screening by Cruelty Free Investors and/or internal research.
Prior pipeline note: Kyverna Therapeutics is a clinical-stage biotechnology company developing cell therapies for autoimmune diseases. Its lead candidate, KYV-101, is an autologous CD19 chimeric antigen receptor T-cell (CAR-T) therapy. The development and testing of such biologic therapies typically involves extensive a
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.